Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial

Affiliations

• ¹ The Third Department of Internal Medicine, Kyorin University School of Medicine, Mitaka, Japan.
• ² Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
• ³ Department of Inflammatory Bowel Disease, Hyogo College of Medicine, Nishinomiya, Japan.
• ⁴ Department of Gastroenterology and Hepatology, National Hospital Organization, Higashi-Ohmi Medical Center, Higashi-Ohmi, Japan.
• ⁵ Department of Gastroenterology, Fukuoka University Chikushi Hospital, Chikushino, Japan.
• ⁶ Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
• ⁷ Division of Gastroenterology, Osaka City General Hospital, Osaka, Japan.
• ⁸ Department of Intestinal Inflammation Research, Hyogo College of Medicine, Nishinomiya, Japan.
• ⁹ Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.
• ¹⁰ Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
• ¹¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
• ¹² Department of Clinical Medicine (Biostatistics), Kitasato University School of Pharmacy, Tokyo, Japan.
• ¹³ Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan.
• ¹⁴ Department of Internal Medicine, Toho University Sakura Medical Centre, Sakura, Japan.
• ¹⁵ Yokoyama IBD Clinic, Aichi, Japan.
• ¹⁶ Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan.
• ¹⁷ Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
• ¹⁸ Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.